SAA receives no government funding and relies on the generous donations from individuals to create and maintain the programs and services aimed at improving the futures of the 3.2 million Americans affected by spondyloarthritis.
Editor’s Note: On November 4, 2017 the Spondylitis…
In recent years, experts in patient care in spondyloarthritis have recognized that a hands on, multi-use approach that…
While fatigue is not unique to spondyloarthritis, it is a rather common symptom of it, and one that…
Question: We hear so much about customized medicine in the media. We know they can test for whether a mood altering drug, such as...
This article will explain and simplify the Social Security disability program and how it generally applies to claims related to spondyloarthritis.
“It is evident that sex plays a very important role in AS. The symptomatic burden of AS tends to be higher in females than in…
With all the current therapies for ankylosing spondylitis (AS)—anti-inflammatory medications, biologics, dietary modifications, and even surgery in some cases— the consensus among most is that…
The biologic drug landscape shifted in March 2015 when The Food and Drug Administration approved the first of a new subclass of treatments to be marketed in the United States—biosimilars. Recently, a second biosimilar product—Inflectra (infliximab-dyyb)—a biologic…
Chloe is an Accredited Practicing Dietitian and Sports Dietitian who specializes in nutrition for arthritis and inflammatory joint disease, food intolerance, and sports...
Input your search keywords and press Enter.
